These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26282097)
1. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma. Nakamura T; Miyabe H; Hyodo M; Sato Y; Hayakawa Y; Harashima H J Control Release; 2015 Oct; 216():149-57. PubMed ID: 26282097 [TBL] [Abstract][Full Text] [Related]
2. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy. Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060 [TBL] [Abstract][Full Text] [Related]
3. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. Nakamura T; Sato T; Endo R; Sasaki S; Takahashi N; Sato Y; Hyodo M; Hayakawa Y; Harashima H J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34215690 [TBL] [Abstract][Full Text] [Related]
4. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice. Wang Z; Celis E Cancer Immunol Immunother; 2015 Aug; 64(8):1057-66. PubMed ID: 25986168 [TBL] [Abstract][Full Text] [Related]
5. Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING. Panchanathan R; Liu H; Xin D; Choubey D Innate Immun; 2014 Oct; 20(7):751-9. PubMed ID: 24131791 [TBL] [Abstract][Full Text] [Related]
6. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer. Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564 [TBL] [Abstract][Full Text] [Related]
7. Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma. Zhang Z; Liu J; Xiao M; Zhang Q; Liu Z; Liu M; Zhang P; Zeng Y Nano Res; 2023; 16(4):5206-5215. PubMed ID: 36405984 [TBL] [Abstract][Full Text] [Related]
8. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer. Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717 [TBL] [Abstract][Full Text] [Related]
9. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511 [No Abstract] [Full Text] [Related]
10. c-di-GMP enhances protective innate immunity in a murine model of pertussis. Elahi S; Van Kessel J; Kiros TG; Strom S; Hayakawa Y; Hyodo M; Babiuk LA; Gerdts V PLoS One; 2014; 9(10):e109778. PubMed ID: 25333720 [TBL] [Abstract][Full Text] [Related]
11. Novel formulation of c-di-GMP with cytidinyl/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity. Yu X; Yu J; Dai H; Deng C; Sun X; Long S; Jiang Z; Jin H; Guan Z; Yang Z Theranostics; 2022; 12(15):6723-6739. PubMed ID: 36185614 [No Abstract] [Full Text] [Related]
13. Pharmacological Activation of cGAS for Cancer Immunotherapy. Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT Front Immunol; 2021; 12():753472. PubMed ID: 34899704 [TBL] [Abstract][Full Text] [Related]
14. Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING. Chin KH; Tu ZL; Su YC; Yu YJ; Chen HC; Lo YC; Chen CP; Barber GN; Chuah ML; Liang ZX; Chou SH Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):352-66. PubMed ID: 23519410 [TBL] [Abstract][Full Text] [Related]
15. [Development of a Drug Delivery System for Cancer Immunotherapy]. Nakamura T Yakugaku Zasshi; 2016; 136(11):1477-1484. PubMed ID: 27803478 [TBL] [Abstract][Full Text] [Related]
16. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide. Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352 [TBL] [Abstract][Full Text] [Related]
17. Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity. An M; Yu C; Xi J; Reyes J; Mao G; Wei WZ; Liu H Nanoscale; 2018 May; 10(19):9311-9319. PubMed ID: 29737353 [TBL] [Abstract][Full Text] [Related]
18. DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy. Kawai M; Nakamura T; Miura N; Maeta M; Tanaka H; Ueda K; Higashi K; Moribe K; Tange K; Nakai Y; Yoshioka H; Harashima H; Akita H Nanomedicine; 2018 Nov; 14(8):2587-2597. PubMed ID: 30170077 [TBL] [Abstract][Full Text] [Related]
19. Bacterial c-di-GMP is an immunostimulatory molecule. Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122 [TBL] [Abstract][Full Text] [Related]
20. Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Nakamura T; Sasaki S; Sato Y; Harashima H Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]